Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(451 sites)

United States

Research Site, Mobile, Alabama

Research Site, Phoenix, Arizona

Research Site, Tucson, Arizona

Research Site, Chula Vista, California